Testimonials

Find out what companies around the world are saying about working with us.
Client location
Client location with testimonial
Algorithme Pharma is an important partner in our development efforts and we recommend them for any ligand-binding requirements. Bryan Tayefeh | Assistant Director Alliance Management Ionis Pharmaceuticals, Inc. Read full testimonial
We have also been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants. Hélène Dulude, B.Pharm., Ph.D. Director, Clinical Development Locemia Solutions ULC Read full testimonial
...the communication between our teams was optimal, from the first protocol draft to the delivery of final report. Maxime Ranger President and CEO gIcare pharma inc Read full testimonial
It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions. Marie-Francoise TEMAM Associate Director, Clinical Operations Idenix, a wholly-owned subsidiary of Merck & Company Read full testimonial

We have retained the services of Algorithme Pharma since 2011 to perform a series of studies ranging from Phase I to Phase III. Consequently, the study populations requested varied from healthy volunteers to populations with a specific disorder such as healthy volunteers suffering from common cold and persons with type 1 or type 2 diabetes (to address our needs). Although Algorithme Pharma has traditionally focused on early stage clinical research, they have clearly shown their ability to recruit for and conduct Phase II and Phase III studies.

Algorithme Pharma has distinguished itself by their very timely responses to request for proposals, protocol development and study execution. They have consistently delivered complete and very well written study reports on time and in compliance with regulatory expectations. We have been impressed and appreciative of the ongoing assistance and scientific guidance and with the remarkable courtesy and professionalism of their entire staff. We have also been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants.

Algorithme Pharma has repeatedly demonstrated a willingness to explore new areas and incorporate tools and technologies to execute new study designs. For example, they have embraced complicated protocols including using insulin to induce hypoglycemia and have welcomed outside expertise to help them further develop internal capabilities.

We have thoroughly enjoyed our relationship with Algorithme and consider them an important partner in our development efforts. We would highly recommend Algorithme Pharma to anyone that needs help with their clinical program.

Sincerely,

Hélène Dulude, B.Pharm., Ph.D.
Director, Clinical Development
Locemia Solutions ULC